Diabetes :: Cholesterol may cause type 2 diabetes
Cholesterol can be a causative factor in Type 2 diabetes, revealed by scientists at Canada’s Vancouver Child and Family Research Institute.
Cholesterol can be a causative factor in Type 2 diabetes, revealed by scientists at Canada’s Vancouver Child and Family Research Institute.
The Centers for Disease Control and Prevention (CDC) today released a report that finds a wide range of variation in the prevalence of coronary heart disease (a narrowing of the arteries that feed the heart), heart attack and angina (chest pain that occurs when the heart does not get enough blood).
While previous biomedical research studies have found that genetics and race increase risk for some diseases, a new look into how researchers study genetic triggers of type 2 diabetes suggests that defining race remains an inexact science, with social and historic facts mixing with biology throughout the research process.
A CNRS team headed by Philippe Froguel (CNRS, University of Lille 2, Pasteur Institute, Imperial College London) and Rob Sladek (McGill University, Montreal, Canada) in a French-British-Canadian collaboration that accounts for about 70 percent of the genetic risk for patients with type two diabetes.
The Scripps Research team, led by neuroscientists Manuel Sanchez-Alavez and Tamas Bartfai, discovered that mice genetically altered to lack a molecule known as the EP3 receptor tend to be more active during their normal sleep cycle and to eat more. In the study, this led to weight increases of up to 30 percent relative to mice with the receptors.
Researchers identified five areas of DNA that could account for 70 percent of the genetic risk for type-2 diabetes.
The first over-the-counter weight loss pill won approval from US FDA health officials. Dieters got a new tool to help them take off the extra pounds.
The number of newly diagnosed end-stage renal disease (kidney failure) patients with diabetes increased by 114% over 10 years, from 1,066 in 1995 to 2,139 in 2004, according to a new report released today by the Canadian Institute for Health Information (CIHI).
Researchers have discovered an enzyme that has an unexpectedly profound impact on fat metabolism. The enzyme is a master regulator that controls metabolic responses to a deficiency of essential amino acids in the diet. The research could lead to treatments for obesity and malnutrition and to preventions for type 2 diabetes and heart attacks.
The first, pan-European guidelines to be published on the treatment of valvular heart disease, diabetes and cardiovascular diseases have made a series of new recommendations which experts hope will contribute to improving the outcome of patients with these diseases.